- Trials with a EudraCT protocol (88)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
88 result(s) found for: Fistulas.
Displaying page 1 of 5.
EudraCT Number: 2013-002932-25 | Sponsor Protocol Number: PISA27062013 | Start Date*: 2013-08-21 |
Sponsor Name:Academic Medical Center | ||
Full Title: Multimodal treatment of perianal fistulas in Crohn's disease: seton vs anti-TNF vs advancement plasty | ||
Medical condition: Perianal fistulas in Crohn's Disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002064-15 | Sponsor Protocol Number: 66176 | Start Date*: 2019-04-15 |
Sponsor Name:Academic Medical Center | ||
Full Title: Treatment of Perianal FIstulas in Crohn’s Disease: Surgical closure vs Anti-TNF | ||
Medical condition: Perianal fistulas in Crohn's Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004590-24 | Sponsor Protocol Number: 1949 | Start Date*: 2005-10-10 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO | |||||||||||||
Full Title: PHASE II PILOT PROTOCOL OF BONEMARROW STAM CELLS MOBILIZATION BY CYTOCHINE STIMULATION IN PATIENTS WITH COMPLEX ANAL FISTULAS AND/OR RECURRENCES AND/OR ANAL-PERIANAL LOCALIZATIONS OF IBD | |||||||||||||
Medical condition: PATIENTS WITH COMPLEX ANAL FISTULAS AND/OR RECURRENCES AND/OR ANAL-PERIANAL LOCALIZATIONS OF IBD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013027-31 | Sponsor Protocol Number: TISSUCOL | Start Date*: 2009-10-26 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE | |||||||||||||
Full Title: Seton or glue for transfinteric anal fistulas? Prospective randomised trial | |||||||||||||
Medical condition: transfinteric anal fistulas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003756-36 | Sponsor Protocol Number: RRK4178 | Start Date*: 2013-02-12 |
Sponsor Name:University Hospital Birmingham NHS Foundation | ||
Full Title: The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas | ||
Medical condition: Arteriovenous fistulas for dialysis in renal failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000064-10 | Sponsor Protocol Number: Fistula-SD-MD | Start Date*: 2011-03-17 |
Sponsor Name:Med. Univ. Wien, Klinik für klinische Pharmakologie | ||
Full Title: Target site pharmacokinetics of linezolid or tigecycline in patients with severe skin and skin structure infections (SSSI) associated with chronic fistulas. | ||
Medical condition: The findings of the present study will enable assessing whether currently employed therapy regimens with linezolid or tigecycline provide effective antimicrobial concentrations at the target site o... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-004239-63 | Sponsor Protocol Number: NL68231.078.18 | Start Date*: 2019-08-23 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Botulinum toxin (BOTOX®) to prevent post-operative pancreatic fistula in patients who undergo distal pancreatectomy. PROFIT study. | |||||||||||||
Medical condition: Post-operative pancreatic fistula | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005363-28 | Sponsor Protocol Number: AST001 | Start Date*: 2006-07-11 |
Sponsor Name:Ocera Therapeutics, Inc. | ||
Full Title: A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS | ||
Medical condition: The two main categories of inflammatory bowel disease (IBD) are ulcerative colitis and Crohn’s disease. Crohn’s disease is characterized by recurring episodes of suppurative inflammation of any par... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) CZ (Completed) BE (Completed) DE (Completed) HU (Completed) AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000455-16 | Sponsor Protocol Number: CYT/Heparin_01/11 | Start Date*: 2011-05-05 |
Sponsor Name:CYATHUS EXQUIRERE PharmaforschungsGmbH | ||
Full Title: Efficacy and local tolerability of topically applied heparin (Heparin 2,400 IU/ml Cutaneous Spray) on the suitability of newly constructed primary arteriovenous Fistulas in haemodialysed patients | ||
Medical condition: This placebo-controlled, randomized and double-blinded pilot study aims to confirm the previous study performed by Stuard et al. (2010) by proving clinically efficacy and local tolerability of topi... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004820-37 | Sponsor Protocol Number: PRGF/AF/2011 | Start Date*: 2012-06-13 | ||||||||||||||||
Sponsor Name:Fundación FISEVI | ||||||||||||||||||
Full Title: Phase II, open-label clinical trial to evaluate the safety and efficacy of platelet-rich plasma and fibrin clot processed with PRGF-System tecnology in the treatment of anal fistulas in Crohn's pat... | ||||||||||||||||||
Medical condition: Perianal fistulas in Crohn's Disease Patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006127-38 | Sponsor Protocol Number: PRGF/AF/SIN/2011 | Start Date*: 2012-06-05 | ||||||||||||||||
Sponsor Name:Fundación FISEVI | ||||||||||||||||||
Full Title: Phase II, open-label clinical trial to evaluate the safety and efficacy of platelet-rich plasma and fibrin clot in processed with PRGF-system technology, in the treatment of anal fistulas in Crohn'... | ||||||||||||||||||
Medical condition: Perianal fistulas in Crohn's Disease Patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-003197-23 | Sponsor Protocol Number: PB_A&A-ASC-FISTULA_1.0 | Start Date*: 2024-12-20 | |||||||||||
Sponsor Name:Jagiellonian University - Medical College | |||||||||||||
Full Title: Multicenter, controlled, randomized clinical trial comparing the efficacy of auto- and allogeneic mesenchymal stromal cells in the healing of Crohn-related anal fistulas | |||||||||||||
Medical condition: Anal or recto-cutaneous or recto-vaginal Crohn-related fistula | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001002-18 | Sponsor Protocol Number: HUGTP-CIR-OFF | Start Date*: 2021-05-04 |
Sponsor Name:Hospital Universitari Germans Trias i Pujol | ||
Full Title: Pathophysiological mechanisms in the development of anal fistula. Oral antibiotics after anal abscess drainage to diminish perianal Fistula Formation: a multicenter, randomized, observer-blind, pla... | ||
Medical condition: Abscess and anal fistulas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004130-28 | Sponsor Protocol Number: ZMK_201501-ONF | Start Date*: 2018-07-25 | |||||||||||
Sponsor Name:Universitätsklinikum Bonn | |||||||||||||
Full Title: Occurence of Oronasal Fistulas (ONF) using a fibrin sealant patch in primary palatoplasty | |||||||||||||
Medical condition: Cleft lip and palate | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015680-14 | Sponsor Protocol Number: allo bmMSCs CD fistula | Start Date*: 2010-05-18 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients with Refractory Perianal Crohn’s Disease | |||||||||||||
Medical condition: single or multiple draining perianal fistulas as a result of Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003090-34 | Sponsor Protocol Number: 1368-0008 | Start Date*: 2019-02-05 | |||||||||||
Sponsor Name:Boehringer Ingelheim RCV GmbH & Co KG | |||||||||||||
Full Title: Mechanism of Action and Clinical Effect of BI 655130 in Patients with fistulizing Crohn’s Disease | |||||||||||||
Medical condition: Fistulizing Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) BE (Completed) DE (Completed) NL (Prematurely Ended) HU (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006064-43 | Sponsor Protocol Number: Cx601-0302 | Start Date*: 2012-09-27 | |||||||||||
Sponsor Name:TiGenix S.A.U. | |||||||||||||
Full Title: A phase III, randomised, double blind, parallel group, placebo controlled, multicentre study to assess efficacy and safety of expanded allogeneic adipose-derived stem cells (eASCs) for the treatm... | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) ES (Completed) IT (Completed) AT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003370-95 | Sponsor Protocol Number: Cx401/FATT1 | Start Date*: 2008-02-06 | |||||||||||
Sponsor Name:CELLERIX, S.L. | |||||||||||||
Full Title: "A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologou... | |||||||||||||
Medical condition: Treatment of complex perianal fistulas in patients without inflammatory bowel disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019973-13 | Sponsor Protocol Number: CQAX576A2209 | Start Date*: 2011-01-14 | ||||||||||||||||
Sponsor Name:Novartis Pharma AG | ||||||||||||||||||
Full Title: A multi-center, randomized, double-blind, active controlled study to assess efficacy, safety and tolerability of the anti-IL13 monoclonal antibody QAX576 in the treatment of perianal fistulas in pa... | ||||||||||||||||||
Medical condition: Treatment of perianal fistulas in patients suffering from Crohn's Disease. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002579-16 | Sponsor Protocol Number: FFF/2013 | Start Date*: 2014-12-09 |
Sponsor Name:C. HOSPITALARIO VIRGEN DEL ROCIO | ||
Full Title: PHASE III CLINICAL TRIAL, single-center, randomized, double blind IN TWO GROUPS PARALLELS TO COMPARE THE EFFICACY AND SAFETY OF RICH PLASMA GROWTH FACTORS (PRGF) IN FRONT OF fibrin glue (TISSUCOL ... | ||
Medical condition: Anal and criptoglandular fistula | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
